当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Obesity-Related Inflammation and Covid-19 Prognosis: Is the White Adipose the Villain?

Joanna Correia-Lima

The emergence novel coronavirus (SARS-CoV-2/COVID-19) has become a worldwide pandemic health threat, causing severe respiratory syndrome in humans. COVID-19 effects, which were first observed in the respiratory tract, are continuously being found and characterized in different organs, and the disease now considered systemic. Recent studies show COVID-19 to have repercussions in the heart, central nervous system, liver, and kidney. Also, it is becoming increasingly clear that the presence of comorbidities is associated with COVID-19 severity and lethality. Thus, the highest fatality rates in infected patients with COVID-19 are related to the presence of diabetes mellitus, cardiovascular diseases (CVD), cancer, and chronic respiratory disease. An unbalanced immune reaction underlines the release of inflammatory cytokines, such as IL-6, IL-1β, IFNγ, inducing the “cytokine storm” in infected patients